Better Context Better Decisions

Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.

$599
Posted in: Other Nov 18 | 2021Novo to Acquire DicernaPurchase Blast
$599
Posted in: Other, SGLT2i Nov 15 | 2021Bayer Hosts Kerendia Investor WebinarPurchase Blast
$599
Posted in: Basal Insulin, Glucagon, Insulin Delivery, Other Nov 10 | 2021MannKind and Xeris Biopharma Q3 ’21 Earnings UpdatesPurchase Blast
$599
Posted in: Bolus Insulin, Glucose Monitoring, Insulin Delivery, Other, SGLT2i Nov 03 | 2021Lexicon, Tandem, Amarin, Intercept, and Amgen Q3 '21 Earnings UpdatesPurchase Blast
novo cover image
$599
Posted in: Basal Insulin, Bolus Insulin, GLP-1RA, Other Nov 03 | 2021Novo Nordisk Q3 '21 Earnings UpdatePurchase Blast
1 2 3 62

Get the Latest Analysis

Stay informed and aligned with frequent updates to keep a pulse on the industry.

If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.